Format: Webcast

1-3 of 3 Activities
Title
Availability
Format
Credits
Launch Date
Buttons
On-Demand
Webcast
1.5
12/22/2023

The Ever-Changing Options for the Treatment of CLL

The treatment landscape for CLL has changed dramatically in the past 10 years. With three approved BTK inhibitors, and several more on the horizon, choosing which agent to use in the first-line continues to present a challenge to hematologists/oncologists and care teams. As the choice of first-line agent has ramifications for future lines of therapy, hematologists/oncologists need to be able to map out the treatment journey while keeping in mind that therapy resistance or intolerance may arise and that AEs may diminish adherence to therapy.

In this Creative Educational Concepts Enduring Webcast, expert faculty will guide learners through the latest clinical data that informs best practices (including sequencing BTKis), the rationale and support for combination therapies, and the need to factor in the needs and preferences of patients.

1.5
12/22/2023

Matthew S. Davids, MD, MMSc

Matthew S. Davids, MD, MMSc

 

Kerry A. Rogers, MD

Kerry A. Rogers, MD

Beth  Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO

Beth  Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO

On-Demand
Webcast
1.00
06/27/2023

Talha Munir, PhD

Talha Munir, PhD

Jennifer R. Brown, MD, PhD





Jennifer R. Brown, MD, PhD

Paolo Ghia, MD, PhD



Paolo Ghia, MD, PhD

Immunotherapy in Upper GI Cancers: A Multidisciplinary Discussion of the Data and Real-World Barriers Faced in Practice

This is a live webcast addressing emerging therapeutic options for gastric, GEJ, and EAC cancers. This activity will address PD-L1 expression and its impact on treatment selection and sequencing, as well as the role of interprofessional care in managing irAEs. 

1.00
06/05/2023

Kurt A. Schalper, MD, PhD


Kurt A. Schalper, MD, PhD

Kelley A. Rone, DNP, RN, AGNP-c

Kelley A. Rone, DNP, RN, AGNP-c

R. Donald Harvey, PharmD, BCOP, FASCO, FCCP, FHOPA




R. Donald Harvey, PharmD, BCOP, FASCO, FCCP, FHOPA

Yelena Y. Janjigian, MD

Yelena Y. Janjigian, MD